Drug Shortage Report for CARBOLITH
| Report ID | 244145 |
| Drug Identification Number | 02011239 |
| Brand name | CARBOLITH |
| Common or Proper name | CARBOLITH |
| Company Name | BAUSCH HEALTH, CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | LITHIUM CARBONATE |
| Strength(s) | 600MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | n/a |
| ATC code | N05AN |
| ATC description | ANTIPSYCHOTICS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2024-11-26 |
| Estimated end date | 2024-12-16 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-11-28 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2024-11-28 | French | Compare |
| v1 | 2024-11-28 | English | Compare |
Showing 1 to 2 of 2